Free tool
FAERS Monitor: Yaz
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021873 or its brand name (Yaz, Drospirenone, Ethinyl Estradiol). Reports on generic versions are filed under their own applications.
Reports
31,300
Serious
24,198
77% of reports
Hospitalization
14,360
Death reported
376
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain10,333
- injury8,764
- pulmonary embolism6,448
- deep vein thrombosis5,876
- anxiety5,267
- emotional distress5,096
- cholecystitis chronic4,476
- gallbladder disorder3,273
- cholelithiasis3,258
- general physical health deterioration2,535
- abdominal pain2,119
- nausea2,023
- anhedonia1,786
- dyspnoea1,582
- thrombosis1,564
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2006 | 19 |
| 2007 | 213 |
| 2008 | 2,509 |
| 2009 | 2,361 |
| 2010 | 1,750 |
| 2011 | 8,672 |
| 2012 | 7,360 |
| 2013 | 3,487 |
| 2014 | 1,798 |
| 2015 | 588 |
| 2016 | 450 |
| 2017 | 278 |
| 2018 | 271 |
| 2019 | 247 |
| 2020 | 239 |
| 2021 | 189 |
| 2022 | 202 |
| 2023 | 203 |
| 2024 | 145 |
| 2025 | 175 |
| 2026 | 143 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,859 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cholecystitis chronicSignal | 4,476 | 1349.3 | 1284.1 | 2,004,429 |
| gallbladder disorderSignal | 3,273 | 150.6 | 145.2 | 397,501 |
| injurySignal | 8,764 | 95.5 | 93.7 | 720,120 |
| cholelithiasisSignal | 3,258 | 74.0 | 71.5 | 211,647 |
| deep vein thrombosisSignal | 5,876 | 66.7 | 65.1 | 346,927 |
| anhedoniaSignal | 1,786 | 48.9 | 46.7 | 78,198 |
| pulmonary embolismSignal | 6,448 | 48.8 | 47.7 | 282,886 |
| emotional distressSignal | 5,096 | 29.5 | 28.7 | 135,081 |
| general physical health deteriorationSignal | 2,535 | 15.0 | 14.5 | 32,639 |
| thrombosisSignal | 1,564 | 13.3 | 12.7 | 17,501 |
| anxietySignal | 5,267 | 12.7 | 12.3 | 56,224 |
| painSignal | 10,333 | 11.5 | 11.3 | 100,107 |
| abdominal painSignal | 2,119 | 6.2 | 5.9 | 9,188 |
| dyspnoea | 1,582 | 1.9 | 1.8 | 667 |
| nausea | 2,023 | 1.7 | 1.6 | 630 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.